DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ. et al.
IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC).
J Clin Oncol 2018;
36: 578 , no. 6_suppl
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.